Protein over-expression in Escherichia coli triggers adaptation analogous to antimicrobial resistance

Microb Cell Fact. 2021 Jan 11;20(1):13. doi: 10.1186/s12934-020-01462-6.

Abstract

Background: The E. coli pET system is the most widely used protein over-expression system worldwide. It relies on the assumption that all cells produce target protein and it is generally believed that integral membrane protein (IMP) over-expression is more toxic than their soluble counterparts.

Results: Using GFP-tagged proteins, high level over-expression of either soluble or IMP targets results in > 99.9% cell loss with survival rate of only < 0.03%. Selective pressure generates three phenotypes: large green, large white and small colony variants. As a result, in overnight cultures, ~ 50% of the overall cell mass produces no protein. Genome sequencing of the phenotypes revealed genomic mutations that causes either the loss of T7 RNAP activity or its transcriptional downregulation. The over-expression process is bactericidal and is observed for both soluble and membrane proteins.

Conclusions: We demonstrate that it is the act of high-level over-expression of exogenous proteins in E. coli that sets in motion a chain of events leading to > 99.9% cell death. These results redefine our understanding of protein over-production and link it to the adaptive survival response seen in the development of antimicrobial resistance.

Keywords: Antimicrobial resistance; BL21(DE3); Escherichia coli; Protein over-expression.

MeSH terms

  • Adaptation, Physiological / genetics
  • Adaptation, Physiological / physiology*
  • Anti-Bacterial Agents / pharmacology
  • Computational Biology / methods
  • Drug Resistance, Bacterial / genetics
  • Escherichia coli / drug effects
  • Escherichia coli / genetics
  • Escherichia coli / metabolism*
  • Escherichia coli Proteins / genetics
  • Escherichia coli Proteins / metabolism*
  • Gene Expression Regulation, Bacterial
  • Membrane Proteins / genetics
  • Membrane Proteins / metabolism*
  • Microbial Viability / drug effects
  • Microbial Viability / genetics
  • Mutation

Substances

  • Anti-Bacterial Agents
  • Escherichia coli Proteins
  • Membrane Proteins